FDA Kicks Off Women’s Health Program With Surgical Mesh Registry

FDA Week, June 27, 2013. FDA’s launch of a new registry for controversial surgical transvaginal mesh products as part of a new program focusing on women’s health could signal the agency is planning to prioritize sex-specific device concerns, a consumer advocate said. “If they start with new patients, it will take years before we get the information that we need,” said Diana Zuckerman, president of the National Research Center for Women & Families.

Read More »

Maryland Playground Closes Due to Possible Toxicity

NBC4 Washington, June 13, 2013. Diana Zuckerman with the Cancer Prevention and Treatment Fund said parents had good reason to be concerned about rubber mulch. “Rubber mulch contains phthalates, which are chemicals that affect hormones, and other chemicals that are known to be harmful to our health,” Zuckerman said.

Read More »

FDA Advisors Vote Against Two Drugs for Menopausal Hot Flashes

Reuters, March 5, 2013. Advisers to the Food and Drug Administration on Monday voted against approval of two drugs designed to reduce the frequency and severity of hot flashes associated with menopause. “The FDA’s advisors did a great job today of carefully considering the scientific evidence,” said Diana Zuckerman, president of the National Research Center for Women & Families.

Read More »